Alzamend Neuro Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.98

+0.11 (+5.88%)

As of Feb 8, 2:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +1,865.7% upside

Low Target $24.59

Average Target $38.92

High Target $51.00

Current Price $1.98

Current
$1.98

Target
$38.92

$24.59 $38.92 avg $51.00

Scenario Analysis

Bear Case

$24.59

1,141.9%

Low target

Base Case

$38.92

+1,865.7%

Avg target

Bull Case

$51.00

+2,475.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$44.73

-95.6% from high

52-Week Low

$27.64

+-92.8% from low

Target vs 52W High

$38.92

-13.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%